Kentucky hemp advocates urge FDA to regulate CBD market for economic revival

In a pivotal meeting on April 10, 2025, the U.S. House Committee on Oversight and Government Reform addressed critical issues surrounding the Food and Drug Administration (FDA) and its handling of illicit products, particularly in the e-cigarette and hemp markets. The discussions highlighted the urgent need for reform to restore public trust in the FDA and ensure consumer safety.

One of the key points raised was the FDA's five-year plan, which many criticized as lacking substantive changes to the Premarket Tobacco Product Application (PMTA) pathway. Stakeholders argued that the current regulatory framework has inadvertently fostered a thriving illicit e-cigarette market. To combat this, the FDA has initiated a multi-agency task force and increased enforcement actions, including seizures and penalties. However, experts emphasized that streamlining the PMTA process is essential for creating a regulated marketplace that can effectively reduce smoking-related deaths and diseases.

The meeting also shed light on the challenges facing the hemp industry, particularly regarding the regulation of hemp-derived products like CBD. Despite the legalization of hemp through the 2018 Farm Bill, the FDA's inconsistent regulatory stance has led to market instability and confusion. Witnesses urged the FDA to adopt a robust regulatory framework that includes quality control standards and labeling requirements to protect consumers and support responsible businesses.

Former FDA officials expressed concerns about the agency's loss of public trust, citing a need for accountability and a focus on tangible outcomes rather than bureaucratic control. They called for a shift towards embracing new scientific advancements and technologies that could enhance food safety and consumer health.

As the committee concluded its discussions, there was a clear consensus on the necessity for the FDA to take decisive action. Stakeholders are hopeful that new leadership within the agency will prioritize effective regulation and restore confidence among consumers, ultimately leading to safer products and a healthier marketplace. The implications of these discussions are significant, as they could shape the future of both the e-cigarette and hemp industries in the United States.